Steinfelder H J, Joost H G
Institute of Pharmacology and Toxicology, University of Göttingen, FRG.
FEBS Lett. 1988 Jan 25;227(2):215-9. doi: 10.1016/0014-5793(88)80901-3.
In isolated rat adipocytes, basal as well as insulin-stimulated 3-O-methylglucose transport was inhibited nearly completely (maximal inhibition: 95%) by the nucleoside transport inhibitors dipyridamole (IC50 = 5 microM), nitrobenzylthioguanosine (20 microM), nitrobenzylthioinosine (35 microM) and papaverine (130 microM). Transport kinetics in the presence of 10 microM dipyridamole revealed a significant increase in the transport Km value of 3-O-methylglucose (3.45 +/- 0.6 vs 2.36 +/- 0.29 mM in the controls) as well as a decrease in the Vmax value (4.84 +/- 0.95 vs 9.03 +/- 1.19 pmol/s per microliter lipid in the controls). Half-maximally inhibiting concentrations of dipyridamole were one order of magnitude higher than those inhibiting nucleoside (thymidine) uptake (0.48 microM). The inhibitory effect of dipyridamole (5 microM) reached its maximum within 30 s. The agent failed to affect insulin's half-maximally stimulating concentration (0.075 nM) indicating that it did not interfere with the mechanism by which insulin stimulates glucose transport. Further, dipyridamole fully suppressed the glucose-inhibitable cytochalasin B binding (IC50 = 1.65 +/- 0.05 microM). The data indicate that nucleoside transport inhibitors reduce glucose transport by a direct interaction with the transporter or a closely related protein. It is suggested that glucose and nucleoside transporters share structural, and possibly functional, features.
在分离的大鼠脂肪细胞中,核苷转运抑制剂双嘧达莫(IC50 = 5 μM)、硝基苄硫鸟苷(20 μM)、硝基苄硫肌苷(35 μM)和罂粟碱(130 μM)几乎完全抑制基础以及胰岛素刺激的3 - O - 甲基葡萄糖转运(最大抑制率:95%)。在存在10 μM双嘧达莫的情况下,3 - O - 甲基葡萄糖的转运动力学显示转运Km值显著增加(3.45 ± 0.6对对照组的2.36 ± 0.29 mM)以及Vmax值降低(4.84 ± 0.95对对照组的9.03 ± 1.19 pmol/s每微升脂质)。双嘧达莫的半最大抑制浓度比抑制核苷(胸苷)摄取的浓度高一个数量级(0.48 μM)。双嘧达莫(5 μM)的抑制作用在30秒内达到最大值。该药物未能影响胰岛素的半最大刺激浓度(0.075 nM),表明它不干扰胰岛素刺激葡萄糖转运的机制。此外,双嘧达莫完全抑制了葡萄糖可抑制的细胞松弛素B结合(IC50 = 1.65 ± 0.05 μM)。数据表明核苷转运抑制剂通过与转运体或密切相关的蛋白质直接相互作用来降低葡萄糖转运。提示葡萄糖和核苷转运体具有共同的结构特征,可能还有功能特征。